North America Pharmaceutical Plastic Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The North America Pharmaceutical Plastic Packaging Market Report is Segmented by Raw Material (Polypropylene, Polyethylene Terephthalate, Low-Density Polyethylene, High-Density Polyethylene, and Other Raw Materials), Product Type (Solid Containers, Dropper Bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials and Ampoules, Cartridges, Syringes, Caps and Closures, and Other Product Types), and Country (United States and Canada). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

North America Pharmaceutical Plastic Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Pharmaceutical Plastic Packaging Market Size

North America Pharmaceutical Plastic Packaging Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 17.50 Billion
Market Size (2030) USD 23.38 Billion
CAGR (2025 - 2030) 5.97 %
Market Concentration Low

Major Players

North America Pharmaceutical Plastic Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Pharmaceutical Plastic Packaging Market with other markets in Packaging Industry

Advanced Packaging

Packaging Equipment

Contract Packaging

Overall Packaging

Packaging Customers

Packaging Forms

North America Pharmaceutical Plastic Packaging Market Analysis

The North America Pharmaceutical Plastic Packaging Market size is estimated at USD 17.50 billion in 2025, and is expected to reach USD 23.38 billion by 2030, at a CAGR of 5.97% during the forecast period (2025-2030).

  • Pharmaceutical packaging materials must be chemically inert, exhibit low water vapor permeability, and be user-friendly. Plastics fulfill these essential criteria. Moreover, as these materials directly contact pharmaceuticals and biological agents, they must adhere to stringent regulations set by authorities. Given their compliance, plastics and polymers have become the go-to choice for pharmaceutical packaging.
  • Polyvinyl chloride (PVC) and polyvinylidene chloride (PVDC) are the primary materials in pharmaceutical packaging. They shield pharmaceutical products from oxygen, odors, moisture, and contamination, making them ideal for blister packs. Their superior organoleptic properties ensure that the flavor of both food and medications remains intact. Additionally, PVC mono films resist sunlight and UV rays, acting as a barrier to contamination and germ spread during production and distribution during the forecast period.
  • Pharmaceutical bottles come equipped with child-resistant caps and closures. These plastic bottles cater to various products, from syrups and capsules to eye drops. Their strength, lightweight nature, and flexibility allow for diverse forms and sizes.
  • The market for pharmaceutical plastic bottles has expanded, driven by technological advancements and a growing reliance on these bottles for both solid and liquid medications. However, fluctuations in crude oil prices and regulatory changes could raise plastic costs, potentially dampening consumer demand and hindering industry growth during the forecast period.
  • As the pharmaceutical sector embraces innovative packaging solutions—like droppers, spray pumps, and resealable openings—the demand for caps and closures is set to rise. Market players are also broadening their product ranges. The industry is leaning toward tamper-evident caps for their child-resistant and contamination-free benefits.
  • With manufacturers shipping products across varied conditions, there's a push for packaging that ensures integrity and longevity. Businesses increasingly prioritize post-consumer recycled (PCR) materials and biodegradable options, signaling a solid move toward sustainability. This eco-friendly trend is expected to gain significant momentum in the coming years, with many companies investing heavily in R&D to create unique and cost-effective solutions as technological advancements in plastic packaging drive product innovations.

North America Pharmaceutical Plastic Packaging Industry Overview

The North American pharmaceutical plastic packaging market is fragmented, featuring prominent players such as Gerresheimer AG, Amcor Group GmbH, Berry Global Group, Inc., Comar LLC, Klockner Pentaplast Group, Nipro Medical Corporation, Bormioli Pharma United States Inc. (a subsidiary of Bormioli Pharma SpA), and Pretium Packaging. These key players are actively working to bolster their presence and capabilities, primarily through strategic expansions.

• March 2024- Bormioli Pharma SpA unveiled plans to bolster its capacity and infrastructure in North America, aligning with the region's growing pharmaceutical market demands. The company aims to solidify its foothold in the region through this strategic expansion.

• January 2024- Amcor Group GmbH expanded its thermoforming capabilities in North America, specifically targeting the healthcare market. This strategic move enables the company to better serve the surging demand from clients in the medical, pharmaceutical, and consumer health sectors.

North America Pharmaceutical Plastic Packaging Market Leaders

  1. Gerresheimer AG

  2. Amcor Group GmbH

  3. Berry Global Group, Inc.

  4. Comar LLC

  5. Klockner Pentaplast Group

  6. *Disclaimer: Major Players sorted in no particular order
North America Pharmaceutical Plastic Packaging Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

North America Pharmaceutical Plastic Packaging Market News

  • July 2024: Amcor Group GmbH completed nine months of receiving recognition for its AmSky™ and AmPrima™, which helped the company earn a place on Walmart’s Circular Connector platform. AmSky is a polyvinyl chloride (PVC) and aluminum-free recycle-ready blister pack for pharmaceuticals. Disrupting the decades-long, over-the-counter standard drug pack, it uses high-density polyethylene (HDPE). AmPrima is a portfolio of recycle-ready packaging solutions for both solid and liquid content.
  • April 2024: Berry Global Group, Inc. completed six months since the launch of a lightweight tube closure solution. This innovative closure, crafted from either virgin polyethylene (PE) and polypropylene (PP) or food-safe post-consumer recycled plastics (rPE and rPP), significantly contributes to reducing greenhouse gas emissions. It is particularly suited for personal care and pharmaceutical applications.

North America Pharmaceutical Plastic Packaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5. MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging
    • 5.1.2 Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
  • 5.2 Market Challenges
    • 5.2.1 Newly Developed Drugs Conflicting with the Packaging Material
    • 5.2.2 Regulatory and Recycling Challenges with the Pharmaceutical Packaging

6. MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polypropylene (PP)
    • 6.1.2 Polyethylene Terephthalate (PET)
    • 6.1.3 Low Density Polyethylene (LDPE)
    • 6.1.4 High Density Polyethylene (HDPE)
    • 6.1.5 Other Raw Materials
  • 6.2 By Product Type**
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Pouches
    • 6.2.7 Vials and Ampoules
    • 6.2.8 Cartridges
    • 6.2.9 Syringes
    • 6.2.10 Caps and Closure
    • 6.2.11 Other Product Types
  • 6.3 By Country
    • 6.3.1 United States
    • 6.3.2 Canada

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Amcor Group GmbH
    • 7.1.3 Berry Global Group, Inc.
    • 7.1.4 Comar LLC
    • 7.1.5 Klockner Pentaplast Group
    • 7.1.6 Nipro Medical Corporation
    • 7.1.7 James Alexander Corporation
    • 7.1.8 Drug Plastics Group
    • 7.1.9 Pretium Packaging
    • 7.1.10 Bormioli Pharma United States Inc. (Bormioli Pharma S.p.A.)
    • 7.1.11 Silgan Plastics (Silgan Holdings Inc.)
  • *List Not Exhaustive

8. INVESTMENT ANALYSIS

9. FUTURE OUTLOOK OF THE MARKET

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Pharmaceutical Plastic Packaging Industry Segmentation

Plastic is a favored choice for pharmaceutical packaging due to its applicability, durability, flexibility, and sustainability. In pharmaceutical packaging, plastic bottles are crafted from various materials, such as polyvinyl chloride, polyethylene, polypropylene, and polystyrene. The industry prioritizes transparent, lightweight, and durable plastics for storage and marketing. Beyond bottles, plastics play a pivotal role in packaging blister packs, sachets, prefilled syringes, inhalers, parenteral solution pouches, and more.

The North America Pharmaceutical Plastic Packaging market is segmented by raw material (polypropylene, polyethylene terephthalate, low-density polyethylene, high-density polyethylene, and other raw materials), product type (solid containers, dropper bottles, nasal spray bottles, liquid bottles, oral care, pouches, vials and ampoules, cartridges, syringes, caps and closures, and other products types), and country (United States and Canada). the market sizes and forecasts are provided in terms of value (USD) for all the above segments.

By Raw Material Polypropylene (PP)
Polyethylene Terephthalate (PET)
Low Density Polyethylene (LDPE)
High Density Polyethylene (HDPE)
Other Raw Materials
By Product Type** Solid Containers
Dropper Bottles
Nasal Spray Bottles
Liquid Bottles
Oral Care
Pouches
Vials and Ampoules
Cartridges
Syringes
Caps and Closure
Other Product Types
By Country United States
Canada
Need A Different Region or Segment?
Customize Now

North America Pharmaceutical Plastic Packaging Market Research FAQs

How big is the North America Pharmaceutical Plastic Packaging Market?

The North America Pharmaceutical Plastic Packaging Market size is expected to reach USD 17.50 billion in 2025 and grow at a CAGR of 5.97% to reach USD 23.38 billion by 2030.

What is the current North America Pharmaceutical Plastic Packaging Market size?

In 2025, the North America Pharmaceutical Plastic Packaging Market size is expected to reach USD 17.50 billion.

Who are the key players in North America Pharmaceutical Plastic Packaging Market?

Gerresheimer AG, Amcor Group GmbH, Berry Global Group, Inc., Comar LLC and Klockner Pentaplast Group are the major companies operating in the North America Pharmaceutical Plastic Packaging Market.

What years does this North America Pharmaceutical Plastic Packaging Market cover, and what was the market size in 2024?

In 2024, the North America Pharmaceutical Plastic Packaging Market size was estimated at USD 16.46 billion. The report covers the North America Pharmaceutical Plastic Packaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Pharmaceutical Plastic Packaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Pharmaceutical Plastic Packaging Industry Report

Statistics for the 2025 North America Pharmaceutical Plastic Packaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Pharmaceutical Plastic Packaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.